SULIMAN SHEHNAAZ — SEC Form 4 filings
SEC reporting owner CIK 1713070. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-26.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-13 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 13,670 shares, $471,423 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 5,359 shares @ $32.59 ($174,644) in 10x Genomics, Inc., filed 2026-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | Director | 5 | — | 4 legs · 7,930 sh · $327,234 | 3 |
| Ultragenyx Pharmaceutical Inc. (RARE) | Director | 3 | — | 1 leg · 5,740 sh · $144,189 | 6 |
Form 4 filings — SULIMAN SHEHNAAZ
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 561 @ $62.73 · Sale (S): 1,646 @ $63.97 | EDGAR |
| 2026-06-18 | 4 | 10x Genomics, Inc. (TXG) | Sale (S): 5,359 @ $32.59 · Sale (S): 364 @ $33.27 | EDGAR |
| 2026-06-08 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 8,829 @ $0 | EDGAR |
| 2026-05-18 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 7,751 @ $0 · Sale (S): 5,740 @ $25.12 · Grant/award (A): 14,058 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 15,357 @ $0 | EDGAR |
| 2025-05-19 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 5,740 @ $0 · Grant/award (A): 10,787 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 5,345 @ $0 · Grant/award (A): 9,900 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 8,649 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1713070 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →